KR101773232B1 - Composition for preventing and treating hangover comprising extracts of hovenia dulcis thunb and extracts of leaves of perilla frutescens britton var - Google Patents
Composition for preventing and treating hangover comprising extracts of hovenia dulcis thunb and extracts of leaves of perilla frutescens britton var Download PDFInfo
- Publication number
- KR101773232B1 KR101773232B1 KR1020140058133A KR20140058133A KR101773232B1 KR 101773232 B1 KR101773232 B1 KR 101773232B1 KR 1020140058133 A KR1020140058133 A KR 1020140058133A KR 20140058133 A KR20140058133 A KR 20140058133A KR 101773232 B1 KR101773232 B1 KR 101773232B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- hangover
- mixture
- extracts
- composition
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 95
- 239000000203 mixture Substances 0.000 title claims abstract description 66
- 206010019133 Hangover Diseases 0.000 title claims abstract description 47
- 235000008584 Hovenia dulcis Nutrition 0.000 title abstract description 13
- 244000010000 Hovenia dulcis Species 0.000 title abstract description 13
- 244000124853 Perilla frutescens Species 0.000 title description 3
- 235000004348 Perilla frutescens Nutrition 0.000 title description 2
- 229940092665 tea leaf extract Drugs 0.000 claims abstract description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 21
- 230000008030 elimination Effects 0.000 claims description 11
- 238000003379 elimination reaction Methods 0.000 claims description 11
- 230000002265 prevention Effects 0.000 claims description 10
- 235000013361 beverage Nutrition 0.000 claims description 5
- 235000013376 functional food Nutrition 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 4
- 239000002775 capsule Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 101
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 58
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 30
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract description 30
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 18
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 9
- 239000004480 active ingredient Substances 0.000 abstract description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 abstract description 6
- 235000015872 dietary supplement Nutrition 0.000 abstract description 5
- 235000013305 food Nutrition 0.000 abstract description 5
- 206010019851 Hepatotoxicity Diseases 0.000 abstract description 3
- 239000012046 mixed solvent Substances 0.000 abstract description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 abstract description 3
- 230000009471 action Effects 0.000 abstract description 2
- 235000013402 health food Nutrition 0.000 abstract description 2
- 231100000304 hepatotoxicity Toxicity 0.000 abstract description 2
- 230000007686 hepatotoxicity Effects 0.000 abstract description 2
- 229940093499 ethyl acetate Drugs 0.000 abstract 1
- 235000019439 ethyl acetate Nutrition 0.000 abstract 1
- 235000013555 soy sauce Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 29
- 210000004369 blood Anatomy 0.000 description 29
- 235000008586 Hovenia Nutrition 0.000 description 11
- 241000405398 Hovenia Species 0.000 description 11
- 239000012153 distilled water Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 9
- 230000002829 reductive effect Effects 0.000 description 9
- 240000000691 Houttuynia cordata Species 0.000 description 8
- 239000013641 positive control Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 7
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- 235000013719 Houttuynia cordata Nutrition 0.000 description 6
- 244000269722 Thea sinensis Species 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 5
- 235000015203 fruit juice Nutrition 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 235000013616 tea Nutrition 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000005194 fractionation Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 2
- 241000723436 Chamaecyparis obtusa Species 0.000 description 2
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 240000000560 Citrus x paradisi Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 235000013717 Houttuynia Nutrition 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102000002852 Vasopressins Human genes 0.000 description 2
- 108010004977 Vasopressins Proteins 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002798 polar solvent Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 229940034610 toothpaste Drugs 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- 229960003726 vasopressin Drugs 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 241000271889 Artemisia japonica Species 0.000 description 1
- 235000017521 Artemisia japonica Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- IWXAZSAGYJHXPX-BCEWYCLDSA-N Bisbentiamine Chemical compound C=1C=CC=CC=1C(=O)OCC/C(SS\C(CCOC(=O)C=1C=CC=CC=1)=C(/C)N(CC=1C(=NC(C)=NC=1)N)C=O)=C(/C)N(C=O)CC1=CN=C(C)N=C1N IWXAZSAGYJHXPX-BCEWYCLDSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 239000001736 Calcium glycerylphosphate Substances 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 241000700112 Chinchilla Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000721156 Chloranthus spicatus Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 239000009141 Houttuynia cordata plant extract Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241001646071 Prioneris Species 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 241000589180 Rhizobium Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 102100026383 Vasopressin-neurophysin 2-copeptin Human genes 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Natural products OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229950009892 bisbentiamine Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 description 1
- 229940095618 calcium glycerophosphate Drugs 0.000 description 1
- 235000019299 calcium glycerylphosphate Nutrition 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002036 chloroform fraction Substances 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- 229960000355 copper sulfate Drugs 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000002038 ethyl acetate fraction Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 235000019225 fermented tea Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 231100000334 hepatotoxic Toxicity 0.000 description 1
- 230000003082 hepatotoxic effect Effects 0.000 description 1
- JQOAQUXIUNVRQW-UHFFFAOYSA-N hexane Chemical compound CCCCCC.CCCCCC JQOAQUXIUNVRQW-UHFFFAOYSA-N 0.000 description 1
- 239000002044 hexane fraction Substances 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000011147 magnesium chloride Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- 230000005813 organ abnormality Effects 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- -1 palmitoyl retinol Chemical compound 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 229940083599 sodium iodide Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- WTWSHHITWMVLBX-DKWTVANSSA-M sodium;(2s)-2-aminobutanedioate;hydron Chemical compound [Na+].[O-]C(=O)[C@@H](N)CC(O)=O WTWSHHITWMVLBX-DKWTVANSSA-M 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- JHYAVWJELFKHLM-UHFFFAOYSA-H tetrasodium;2-hydroxypropane-1,2,3-tricarboxylate;iron(2+) Chemical compound [Na+].[Na+].[Na+].[Na+].[Fe+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O JHYAVWJELFKHLM-UHFFFAOYSA-H 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
우리나라 천연자원인 헛개나무 추출물 및 차즈기 잎 추출물 혼합물을 유효성분으로 하는 숙취 해소에 작용하는 고부가가치 기능성 건강식품을 제공하는 것으로 천연원료를 사용함으로써 장기간 복용하여도 부작용 없이 안전한 숙취 해소용 식품 조성물을 제공하고자한다. 상기 목적을 달성하기 위해, 본 발명은 물, 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올 또는 이들의 혼합용매 중 어느 하나로부터 가용한 추출한 헛개나무 추출물 및 차즈기 잎 추출물 혼합물 또는 헥산, 클로로포름, 디클로메탄 및 에틸아세테이트 중에서 선택되는 어느 하나의 비극성가용추출물을 유효성분으로 포함하는 숙취 해소 식품 조성물을 제공한다. 본 발명의 숙취해소용 식품 조성물은 인체에 부작용이 없으면서 숙취해소 작용이 우수하고 간독성 보호효과가 뛰어나기 때문에 이를 유효성분으로 함유하는 건강보조식품은 복용이 용이하고 장기간 보관이 가능하여 음주전·후의 숙취해소 및 간장 보호에 유용하게 사용될 수 있다.The present invention provides a high-value-added functional health food which is effective in relieving hangover, comprising a mixture of Hovenia dulcis extract and tea leaf extract, which is a natural resource of Korea, and can be safely used for long- . In order to achieve the above object, the present invention relates to a mixture of extracts of Hovenia dulcis Thunb extract and tea leaf extract extracted from any one of water, methanol, ethanol, propanol, isopropanol, butanol or a mixed solvent thereof or a mixture of hexane, chloroform, And ethylacetate as an active ingredient. The present invention provides a hangover-free food composition comprising, as an active ingredient, any one of non-polar soluble extracts selected from the group consisting of: Since the food composition of the present invention for hangover is excellent in the hangover relieving action and excellent in the protection against hepatotoxicity without side effects on the human body, the health supplement containing it as an active ingredient is easy to take and can be stored for a long time, It can be useful for hangover relief and soy sauce protection.
Description
본 발명은 숙취 해소 식품 조성물에 관한 것으로서, 보다 구체적으로는 천연원료를 이용하여 독성 및 부작용 없이 안전하게 사용될 수 있는 헛개나무 열매 추출물과 차즈기 잎 추출물 혼합물을 함유하는 숙취 해소 조성물에 관한 것이다.
The present invention relates to a hangover-eliminating food composition, and more particularly to a hangover rescue composition containing a mixture of Hovenous Fruit Extract and Charpy Leaf Extract which can be safely used without toxicity and side effects by using a natural raw material.
차즈기(蘇葉; Perilla frutescens (L.) Britton var. acuta (Thunb.) Kudo)는 생물학적 분류로 피자식물문, 쌍떡잎식물강, 꿀풀과에 속하는 1년초 약용식물로서 우리나라와 중국에 분포한다. Perilla frutescens (L.) Britton var. Acuta (Thunb.) Kudo) is a biennial medicinal plant belonging to the pizza plant door, dicotyledonous plant river, and Lamiaceae family in the biological classification and is distributed in Korea and China.
줄기는 곧추서고 네모지며 전주(全株)에 자색을 띠고 향기가 있고, 잎은 대생하고 넓은 난형으로 끝은 뾰족하고 밑은 둥글거나 다소 쐐기 모양이며 가장자리에 톱니가 있으며, 양면에 털이 있으며 특히 맥 위에 긴 털이 있고 엽병이 길다. 꽃은 8~9월에 연한 자색으로 피고 줄기와 가지 끝, 위쪽의 잎짬에 총상화서로 달린다. 꽃받침은 2개로 갈라지고 위쪽 것은 다시 3열, 아래쪽 것은 2열하며 통부의 내외에 털이 있다. 화관은 짧은 통상 순형이고 하순이 상순보다 약간 길며 수술은 2강웅예이고 과실은 분과로 둥글며 꽃받침 안에 들어 있다. 본종은 전체에 자색을 띠며 분과는 원형이고 그물무늬가 있다. 잎과 줄기는 약용으로 쓰이고 어린잎과 종자는 식용한다.The stem is straight and square, all the plants are purple and fragrant, the leaves are broad, ovate, the ends are pointed, the bottom is round or somewhat wedge shaped, the edge has sawtooths, It has long hairs on it and a long petiole. Flowers bloom in August to September with light purple color, and hang on to the stem of the stem, the tip of the branch, and the leaf blade of the upper part. The calyx is divided into two, the upper one is again three rows, the lower one is two rows, and there are hairs on the inside and outside of the tubule. The corolla is short, straight, and the bottom is slightly longer than the top, the stamen is round and the fruit is round with a branch. This species is purple throughout, the circle is circular, and there is a net pattern. Leaves and stems are used for medicinal purposes; young leaves and seeds are edible.
어린 잎은 들깨잎과 구분이 어려울 정도로 비슷하며, 차즈기에 들어 있는 페릴알데히드로 만든 설탕은 정상 설탕보다 2,000배 정도 강한 감미료이므로 담배·장·치약 등에 사용한다. 잎이 자줏빛이 아니고 녹색인 것을 청소엽(for. viridis)이라고 한다. 청소엽은 꽃이 흰색이고 향기가 차즈기보다 강하며 약재로 많이 사용한다.Young leaves are hardly distinguishable from perilla leaves, and sugar made from perylaldehyde in charcoal is about 2,000 times stronger than normal sugar, so it is used for tobacco, toothpaste and toothpaste. It is said that the leaves are not purple, but green, and they are called for for viridis. The cleaned leaves are white flowers and smell stronger than those of tea.
헛개나무는 높이 10m이고 수피는 검은 빛을 띤 회색으로 세로로 갈라지고 벗겨진다. 잎은 어긋나고 넓은 달걀모양 또는 타원모양으로 가장자리에 잔거치가 있으며, 잎의 앞면은 녹색으로 털이 없고 뒷면은 연한 녹색으로 맥위에 털이 없거나 있다. 열매는 9~10월에 익으며 둥근 모양이고 갈색을 띄며, 낙엽활엽교목이고 원산지는 한국이고 전국 각지에 분포한다.The hinoki is 10m high and the bark is dark gray and cracked and peeled vertically. Leaves are alternate phyllotaxis, oval or oval shape, with a frog on the edge. The front side of the leaf is green and has no hairs. The back side is light green with no hairs on the veins. Fruits ripen in September ~ October, rounded, brownish, deciduous broad-leaved arboreous tree, native to Korea and distributed throughout the country.
한편, 현대인들에게 음주는 필요 불가결한 것으로 과다한 음주는 일시적으로 두근거림, 두통, 갈증, 멀미, 위장장애, 설사 등의 숙취현상(hangover)을 유발하며, 만성적으로는 지방간, 간경화 등의 질환을 일으킬 수 있다. 숙취현상 중 두통은 두뇌 혈관의 확장 작용으로 인한 것이며, 갈증과 탈수현상은 에탄올이 뇌하수체에서 분비되는 항이뇨호르몬인 바소프레신의 분비를 억제함으로써 생기는 에탄올의 이뇨작용 때문이다. 또한, 위장장애 등의 소화기관 이상은 위산분비의 증가 때문으로, 가장 큰 원인은 간세포에 축적된 에탄올(ethanol)이나 아세트알데히드(acetaldehyde)의 독성 작용에 의한 것이다.Drinking is indispensable for modern people. Excessive drinking temporarily causes hangover such as throbbing, headache, thirst, nausea, gastrointestinal disorder, diarrhea, etc., and chronic diseases such as fatty liver and cirrhosis Can cause. Headaches during hangover are due to the expansion of brain blood vessels. Thirst and dehydration are caused by the diuretic effect of ethanol, which is produced by the suppression of the secretion of vasopressin, an antidiuretic hormone secreted by ethanol in the pituitary gland. In addition, digestive organ abnormalities such as gastrointestinal disorders are caused by an increase in gastric acid secretion, and the main cause is toxicity of ethanol or acetaldehyde accumulated in hepatocytes.
이와 같은 에탄올의 분해기작 뿐 아니라 에탄올의 독성학적 연구에 대해서도 다양하게 이루어졌는데, 에탄올의 독성은 신경학적 측면에서 관찰될 뿐만 아니라 유전학적으로도 영향을 끼친다는 보고가 있다(J.Caballeria, et al., Life Sci.,41: 1021-1727, 1986). 최근 들어, 에탄올의 독성을 경감시키거나 독성의 발현을 저해할 수 있는 많은 물질에 대한 연구와 실험이 진행되고 있으며, 그 결과 천연식품이나 한약재료로부터 추출한 성분을 함유한 다양한 건강보조식품이 이와 관련되어 개발되고 있다(김정한 등, 한국농화학회지, 38(6): 549-553, 1995).In addition to the mechanism of ethanol degradation, toxicological studies of ethanol have been done in various ways. It has been reported that the toxicity of ethanol is not only observed neurologically but also genetically influenced (J. Caballeria, et al Life Sci., 41: 1021-1727, 1986). In recent years, many researches and experiments have been conducted on a number of substances that can reduce the toxicity of ethanol or inhibit the expression of toxins, and as a result, a variety of health supplements containing ingredients extracted from natural or herbal ingredients (Kim JJ, et al., Journal of the Korean Society of Agricultural Chemistry, 38 (6): 549-553, 1995).
따라서 본 발명에서는 우리나라의 전통적인 식물자원을 활용할 목적으로 헛개나무 추출물과 차즈기 잎 추출물 혼합물을 이용하여 독성 및 부작용 없이 안전하게 사용될 수 있는 헛개나무 추출물과 차즈기 잎 추출물 혼합물을 함유하는 숙취 해소 조성물을 제공하고자 한다.
Accordingly, the present invention provides a hangover rescue composition containing a mixture of Hovenia dulciflora extract and Leaf leaf extract, which can be safely used without toxicity and side effects by using a mixture of Hovenia dulcis extract and Leaf leaf extract for utilization of traditional plant resources of Korea I want to.
우리나라 천연자원인 헛개나무열매 추출물과 차즈기 잎 추출물 혼합물을 유효성분으로 하는 숙취 해소에 작용하는 고부가가치 기능성 건강식품을 제공하는 것으로 천연원료를 사용함으로써 장기간 복용하여도 부작용 없이 안전한 숙취 해소 조성물을 제공하고자한다.
The present invention provides a high-value-added functional health food which acts as a hangover relieving agent comprising a mixture of Hovenous Fruit extract and Chazju leaf extract, which are natural resources of Korea, and provides safe hangover elimination composition without side effects even when taken for a long time by using natural raw materials I want to.
상술된 본 발명의 목적을 달성하기 위해, 본 발명은 헛개나무열매 추출물과 차즈기 잎 추출물 혼합물 또는 이들의 비극성가용추출물을 유효성분으로 포함하는 숙취 해소 조성물을 제공한다.In order to accomplish the object of the present invention described above, the present invention provides a hangover resolution composition comprising as an active ingredient, a mixture of a horno fruit extract and a tea leaf extract or a non-polar soluble extract thereof.
헛개나무열매 추출물과 차즈기 잎 추출물 혼합물은 물, 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올 또는 이들의 혼합용매로 이루어진 군 중에서 선택된 1종 이상을 추출용매로 사용하여 추출한 것 일수 있으며, 추출용매를 사용하여 추출한 차즈기 잎 조추출물에 비극성가용 용매로서 헥산, 클로로포름, 디클로메탄 및 에틸아세테이트이들의 혼합물로 이루어진 군으로부터 선택된 어느 하나를 분획용매로 사용하여 분획한 것일 수 있다.The Houttuynia fruit extract and the tea leaf extract mixture may be extracted by using at least one selected from the group consisting of water, methanol, ethanol, propanol, isopropanol, butanol or a mixed solvent thereof as an extraction solvent. , And a non-polar solvent which is obtained by fractionating the crude extract of Chamaecyparis obtusa using any one selected from the group consisting of hexane, chloroform, dichloromethane and ethyl acetate as a fraction solvent.
또한, 상기 추출물을 유효성분으로 포함하는 것을 특징으로 하는 숙취 예방 및 해소용 음료가 제공될 수 있고 추출물은 전체 숙취해소 조성물의 0.01 내지 100중량%로 포함될 수 있다.
In addition, a drink for prevention and elimination of hangover may be provided, which comprises the extract as an active ingredient, and the extract may be contained in an amount of 0.01 to 100% by weight of the total hangover resolution composition.
본 발명의 숙취해소용 조성물은 인체에 부작용이 없으면서 숙취해소 작용이 우수하고 간독성 보호효과가 뛰어나기 때문에 이를 유효성분으로 함유하는 건강보조식품은 복용이 용이하고 장기간 보관이 가능하여 음주전·후의 숙취해소 및 간장 보호에 유용하게 사용될 수 있다.
Since the composition for the hangover of the present invention is excellent in the effect of eliminating the hangover and excellent in the effect of protecting the hepatotoxicity without side effects on the human body, the health supplement containing it as an active ingredient is easy to take and can be stored for a long time, And can be usefully used for the prevention of liver and liver.
도 1은 차즈기 잎 열수 추출물의 추출과 분획 모식도를 나타낸다.
도 2는 헛개나무열매 열수 추출물의 추출 모식도를 나타낸다.
도 3은 헛개나무열매 추출물과 차즈기 잎 추출물 혼합물에 대한 혈중알코올 농도 측정결과를 나타낸다.
도 4는 헛개나무열매 추출물과 차즈기 잎 추출물 혼합물의 숙취해소 관찰실험에서 혈중알코올농도를 양성대조군인 시중숙취음료(YM)를 기준으로 비교한 그래프를 나타낸다.Fig. 1 shows the extraction and fractionation diagrams of the hot-water extract of Chaji leaf.
Fig. 2 shows a schematic diagram of the extraction of the hot-water extract of Hovenia dulcis.
Fig. 3 shows the results of blood alcohol concentration measurement on a mixture of Houttuynia cordata fruit extract and Cha-ki leaf extract.
FIG. 4 is a graph showing a comparison of the blood alcohol concentration with the positive control hanging drink (YM) in the hangover resolution observation experiment of a mixture of Houttuynia cordata fruit extract and Chauzi leaf extract.
본 발명에서는 헛개나무열매 추출물과 차즈기 잎 추출물 혼합물 또는 비극성가용 추출물을 유효성분으로 포함하는 숙취 예방 및 해소용 조성물이 제공된다.The present invention provides a composition for prevention and elimination of hangover comprising a mixture of Hovenous Fruit extract, Charpy Leaf Extract or nonpolar soluble extract as an active ingredient.
헛개나무열매 추출물과 차즈기 잎 추출물은 물, 메탄올, 에탄올, 프로판올, 이소프로판올, 부탄올 또는 이들의 혼합용매로 이루어진 군 중에서 선택된 1종 이상을 추출용매로 사용하여 추출한 것일 수 있고, 추출 용매를 사용하여 추출한 헛개나무 추출물과 차즈기 잎 추출물에 비극성가용 용매로서 헥산, 클로로포름, 디클로메탄 및 에틸아세테이트 및 이들의 혼합물로 이루어진 군으로부터 선택된 어느 하나를 분획용매로 사용하여 분획한 것일 수 있다.The fruit extract of Hovenia dulcis Thunbergii and the tea leaf extract may be obtained by extracting at least one selected from the group consisting of water, methanol, ethanol, propanol, isopropanol, butanol or a mixed solvent thereof as an extraction solvent, The non-polar soluble solvent extracted from the Hovenia dulcis extract and the tea leaf extract may be fractionated using any one selected from the group consisting of hexane, chloroform, dichloromethane and ethyl acetate, and mixtures thereof as a fraction solvent.
또한 상기 추출물 혼합물은 전체 조성물의 0.01 내지 95 중량%의 양으로 포함되어 숙취 예방 및 해소용 음료로서 제공될 수 있고, 추출물 혼합물의 제공 양은 체중 kg당 100-200mg의 양으로 제공될 수 있다.The extract mixture may be contained in an amount of 0.01 to 95% by weight of the total composition, and may be provided as a beverage for prevention and elimination of hangover, and the amount of the extract mixture to be provided may be provided in an amount of 100-200 mg per kg of body weight.
숙취 예방 및 해소용 조성물의 추출방법은 헛개나무열매와 차즈기 잎 각각을 증류수로 수세한 다음 증류수와 혼합하여 열수추출하는 단계; 상기 추출물을 여과한 농축하여 동결건조하는 단계; 상기 단계의 추출물을 분획용매에 용해시켜 분획물을 얻어 감압여과 장치로 여과, 농축하여 동결건조하는 단계를 포함하는 추출방법이 제공된다.A method for extracting a composition for prevention and elimination of hangover comprises the steps of: washing each of Hovenous Fruit and Charan leaf with distilled water, mixing with distilled water, and extracting it with hot water; Filtering and concentrating the extract to freeze-dry the extract; Dissolving the extract of the above step in a fraction solvent to obtain fractions, filtering and concentrating the fractions with a vacuum filter, and freeze-drying the extract.
이하 첨부된 도면을 참조하여 본 발명의 실시예를 상세히 설명한다. 하기에 서 본 발명을 설명함에 있어서, 공지기능 또는 구성에 대한 구체적인 설명이 본 발명의 요지를 불필요하게 흐릴 수 있다고 판단되는 경우에는 그 상세한 설명을 생략하였다.
Hereinafter, embodiments of the present invention will be described in detail with reference to the accompanying drawings. In the following description of the present invention, detailed description of known functions and configurations incorporated herein will be omitted when it may make the subject matter of the present invention rather unclear.
1. 차즈기 잎 열수 추출물 및 분획물 제조1. Preparation of hot water extracts and fractions of Leaf tea
도 1는 차즈기 잎 추출물 및 유기용매에 의한 분획물을 얻는 과정을 나타낸다. 차즈기 3kg을 증류수로 수세한 다음, 증류수 30L를 가하고, 전기약탕기로 100℃에서 3시간 동안 가열, 추출하였다.Fig. 1 shows a process for obtaining a tea leaf extract and an organic solvent fraction. 3 kg of water was washed with distilled water, and 30 L of distilled water was added thereto, and the mixture was heated and extracted at 100 캜 for 3 hours with an electric bath.
추출된 용액은 400 메쉬 여과포로 여과한 다음 감압회전농축기로 농축하였다. 여과 후 남은 잔사에 다시 동량의 증류수를 사용하여 동일 과정으로 2번 더 추출, 여과 및 감압 농축한다. 농축된 열수추출물을 동결건조기 (Freeze dryer)에서 동결건조 하였다. 차즈기 잎 열수추출물 390g(13.01%)을 얻었다.
The extracted solution was filtered with 400 mesh filter cloth and then concentrated with a rotary evaporator under reduced pressure. After the filtration, the same amount of distilled water is again used for the remaining residue, which is further extracted twice, filtered and concentrated under reduced pressure. The concentrated hot water extract was lyophilized in a freeze dryer. And 390 g (13.01%) of hot water extract of Chazugi leaf were obtained.
2. 차즈기 잎의 극성용매, 비극성용매 가용 분획물의 제조2. Preparation of polar solvent and non-polar solvent-soluble fraction of tea leaves
도 1에 도시된 바와 같이 제조된 열수추출물을 유기 용매를 이용하여 분획물을 제조하였다. 차즈기 잎의 극성용매, 비극성용매 가용 분획물의 제조는 차즈기 잎 열수 추출물 250g을 증류수 1L에 완전히 용해시킨 후 분획 여두 깔대기에 넣고 헥산(Hexane) 1L를 첨가하여 water층과 hexane 층을 분리하였고 이와 같은 공정을 3번 반복하였다.The hot-water extract prepared as shown in Fig. 1 was fractionated using an organic solvent. The production of polar and nonpolar solvent soluble fractions of
동일한 과정을 통해 클로로포름 (chloroform), 에틸아세테이트(ethyl acetate), 부탄올(butanol)을 순차적으로 가하여 각 분획물을 얻었고, 얻어진 각각의 분획물을 감압여과 장치로 여과하여 농축한 후 동결건조하여 용매를 완전히 제거한 뒤 본 실험에 사용하였다.
Chloroform, ethyl acetate and butanol were sequentially added through the same procedure to obtain fractions. Each of the fractions thus obtained was filtered with a vacuum filtration apparatus and concentrated. The extract was lyophilized to remove the solvent completely This test was used for this experiment.
2.1. 헥산 가용성 분획 분리2.1. Hexane-soluble fraction separation
차즈기 열수추출물 250g을 lL의 증류수에 완전히 용해시킨 후에 분획 여두 깔대기에 넣고 헥산 1L를 첨가하여 헥산 불용성층(수층)과 헥산가용성층을 분리하였다. 다시 헥산 불용성층(수층)을 대상으로 동일한 공정을 3번 반복하여 헥산 불용성 분획 및 가용성 분획을 수집하였다.
After 250 g of the hot water extract of Chazu was completely dissolved in 1 L of distilled water, the mixture was placed in a separating funnel and 1 L of hexane was added to separate the hexane insoluble layer (water layer) and the hexane soluble layer. Again, the hexane insoluble fraction and the soluble fraction were collected by repeating the same process three times for the hexane insoluble layer (water layer).
2.2.클로로포름 가용성 분획분리2.2. Isolation of Soluble Fraction from Chloroform
헥산불용성 분획(수층)에 클로로포름 5L를 가하여 섞은 후에 클로로포름가용성 분획 및 불용성 분획을 분리하였고, 클로로포름 불용성층(수층)을 대상으로 동일한 공정을 3번 반복하여 클로로포름 불용성 분획 및 가용성 분획을 수집하였다.
The hexane insoluble fraction (aqueous layer) was mixed with 5 L of chloroform, and then the chloroform-soluble fraction and the insoluble fraction were separated. The chloroform-insoluble fraction and the soluble fraction were collected by repeating the same process three times for the chloroform insoluble layer (water layer).
2.3.에틸아세테이트 가용성 분획분리2.3. Ethyl acetate soluble fractionation
클로로포름 불용성 분획(수층)에 에틸아세테이트 5L를 가하여 섞은 후에 에틸아세테이트 가용성 분획 및 불용성 분획을 분리하였고, 에틸아세테이트 불용성층(수층)을 대상으로 동일한 공정을 3번 반복하여 에틸아세테이트 불용성 분획 및 가용성 분획를 수집하였다.
After adding 5 L of ethyl acetate to the chloroform insoluble fraction (aqueous layer), the ethyl acetate soluble fraction and the insoluble fraction were separated. The ethyl acetate insoluble layer (water layer) was subjected to the same process three times to collect the ethyl acetate insoluble fraction and the soluble fraction Respectively.
2.4. 부탄올 가용성 분획분리2.4. Butanol soluble fraction fractionation
에틸아세테이트 불용선 분획(수층)에 부탄올 5L를 가하여 섞은 후에 부탄올 가용성 분획 및 불용성 분획을 분리하였고, 부탄올 불용성층을 대상으로 동일한 공정을 3번 반복하여 부탄올 불용성 분획 및 가용성 분획을 수집하였다.
The butanol insoluble fraction and the insoluble fraction were separated by adding 5 L of butanol to the ethyl acetate insoluble fraction (water layer), and the butanol insoluble fraction was repeated three times to collect the butanol insoluble fraction and the soluble fraction.
2.5 차즈기 잎 열수추출물 및 분획물 수득2.5 Obtained Hot Water Extract and Fraction of Leaf Leaf
차즈기 잎 열수추출물 250g에서 헥산 가용성 분획, 클로로포름 가용성 분획, 에틸아세테이트 가용성 분획 및 부탄올 가용성 분획을 감압 농축한 후에 동결건조하여 헥산분획 0.015g, 클로로포름 분획 0.57g, 에틸아세테이트 분획 3.62g, 부탄올 분획 54.74g을 얻어 시료로 사용하였다.
The hexane-soluble fraction, the chloroform-soluble fraction, the ethyl acetate-soluble fraction and the butanol-soluble fraction were concentrated under reduced pressure and then lyophilized to obtain 0.015 g of the hexane fraction, 0.57 g of the chloroform fraction, 3.62 g of the ethyl acetate fraction, g was used as a sample.
3. 헛개 열매 열수 추출물 제조3. Production of hot-water extract of Hovenia fruit
도 2는 헛개 열매 추출물을 얻는 과정을 나타낸다. 헛개 열매 1kg을 증류수로 수세한 다음, 증류수 20L를 가하고, 전기약탕기로 100℃에서 3시간 동안 가열, 추출하였다.Fig. 2 shows the process of obtaining houtto fruit extract. One kilogram of the hoven fruit was washed with distilled water, and then 20 L of distilled water was added thereto, and the mixture was heated and extracted at 100 DEG C for 3 hours with an electric bath.
추출된 용액은 400 메쉬 여과포로 여과한 다음 감압회전농축기로 농축하였다. 여과 후 남은 잔사에 다시 동량의 증류수를 사용하여 동일 과정으로 2번 더 추출, 여과 및 감압 농축한다. 농축된 열수추출물을 동결건조기 (Freeze dryer)에서 동결건조 하였다. 헛개 열매 열수추출물 298.2g(29.8%)을 얻었다.
The extracted solution was filtered with 400 mesh filter cloth and then concentrated with a rotary evaporator under reduced pressure. After the filtration, the same amount of distilled water is again used for the remaining residue, which is further extracted twice, filtered and concentrated under reduced pressure. The concentrated hot water extract was lyophilized in a freeze dryer. 298.2 g (29.8%) of hot water extract of Hovenia fruit was obtained.
4. 실험 동물사육 및 혈청 분리4. Experimental animal breeding and serum separation
헛개나무열매 추출물과 차즈기 잎 추출물 혼합물의 숙취 예방 및 해소효과 측정을 위한 실험동물로서 생후 5주령 된 체중 15-20g 내외의 수컷 ICR mouse를 (주)샘타코(SAMTACO, Korea)부터 구입 하여 동물사육실에서 일정한 조건(온도: 22±2℃, 습도:50±5%, 명암: 12시간 light/dark cycle)주기로 일주일 간 적응시킨 후 사용하였다.
Male ICR mice weighing 15 to 20 g at 5 weeks of age were purchased from SAMTACO, Korea as an experimental animal for the prevention of hangover and the effect of preventing the hangover of a mixture of Houttuynia cordata L. and Chazuri leaf extract. The animals were adapted for one week at a constant temperature (temperature: 22 ± 2 ° C, humidity: 50 ± 5%, darkness: 12 hours light / dark cycle)
4.1 실험동물 알콜투여 및 혈청분리4.1 Experimental animal Alcohol administration and serum separation
실험군은 6마리씩 정상군(normal),대조군(control), 양성대조군(Positive control), 시료 투여군으로 나누었다. 실험에 앞서 사료 섭취로 인해 나타날 수 있는 위장관을 통한 알코올의 흡수 방해 현상을 배제하기 위해 18시간 동안 절식시켰으며 이때 물은 제한없이 공급하였다.Six experimental groups were divided into normal (normal), control (control), positive control (control), and sample administration groups. Prior to the experiment, the animals were fasted for 18 hours to exclude the absorption of alcohol through the gastrointestinal tract, which may be caused by feed intake, and water was supplied without restriction.
헛개나무열매 열수 추출물과 차즈기 잎 열수추출물의 혼합 비율은 1: 0.5, 1:1(헛개나무열매 열수추출물 : 차즈기 잎 열수추출물)의 비율로 경구투여 하였다. 구체적으로, 헛개나무열매 열수추출물 200mg/kg에 차즈기 잎 열수 추출물을 각각 100, 200mg/kg을 혼합하여 경구투여 하였다. 또한, 단독으로 헛개나무열매 열수추출물 200, 400mg/kg, 차즈기 잎 열수 추출물 200, 400mg/kg 을 각각 경구투여 하였고 양성대조군으로 여명 200, 400mg/kg(주성분 함량 기준)을 경구투여 하였다.The mixing ratio of hot water extract of Houttuynia cordata and hot water extract of Chazji leaf was orally administered at a ratio of 1: 0.5, 1: 1 (hot water extract of Houttuynia cordata: hot water extract of Chazju leaf). Specifically, 200 mg / kg of hot water extract of Hovenia duli fruit was mixed with 100 and 200 mg / kg of hot water extract of Chaziri leaf, respectively, orally. In addition, oral administration of 200, 400 mg / kg, and 200 mg / kg (based on the main component) of the extracts of Hovenia duli fruit juice, 200 and 400 mg / kg, respectively.
알코올 투여는 25% 주정을 체중 kg당 3g 수준으로 1회 경구 투여하였다. 대조군은 시료 대신 증류수를 경구 투여하였고 정상군은 아무런 조건도 주지 않았다. 혈청 중 알코올 농도 측정을 위한 채혈은 알코올 투여 후 diethyl ether 마취상태에서 0.5시간, 1시간, 2시간 그리고 4시간 후에는 안와 채혈을 하였다. 채혈한 혈액은 2시간 정도 실온에서 방치시킨 후 600xg에서 15분간 원심분리하여 혈청을 분리하여 알코올 농도 측정에 사용하였다.
Alcohol was given once at a level of 3g per kg body weight of 25% alcohol. The control group received oral administration of distilled water instead of the sample and no conditions were given to the normal group. Blood samples were taken at 0.5 hour, 1 hour, 2 hours, and 4 hours after dihydrate ether anesthesia with alcohol. The collected blood was allowed to stand at room temperature for 2 hours, centrifuged at 600 xg for 15 minutes, and the serum was separated to measure the alcohol concentration.
5. 5. 헛개나무Hinoki 열매 추출물과 Fruit extract 차즈기Charge 잎 추출물 혼합물에 대한 혈중 알코올 농도 측정 실험 Blood alcohol concentration test on leaf extract mixture
혈중 알코올 농도는 EtOH assay kit (biovision, USA)를 이용하여 측정하였다. 혈액에서 분리된 혈청 5ul를 EtOH assay buffer로 1:10으로 묽힌 다음, reaction mixture 50ul와 혼합하였다. 실온, 암실에서 30분 동안 방치한 다음, 570nm에서 흡광도를 측정하였고, 에탄올 검량선을 이용하여 혈중 알코올 농도를 계산하였다.Blood alcohol concentration was measured using the EtOH assay kit (biovision, USA). 5μl of serum isolated from blood was diluted 1:10 with EtOH assay buffer and mixed with 50μl of reaction mixture. After standing for 30 minutes at room temperature in a dark room, the absorbance was measured at 570 nm and the alcohol concentration in the blood was calculated using an ethanol calibration curve.
헛개나무열매 추출물 및 차즈기 잎 추출물 혼합물을 에탄올을 투여하기 30분 전에 경구투여하고, 에탄올을 투여한 후 30분, 1시간, 그리고 2시간마다 혈액을 채취하여 혈중 알코올 농도를 측정한 결과, 도 3에 나타낸 바와 같이 에탄올을 투여한 후 2시간 대에서 혈중알코올 농도감소 효과를 확인 및 비교할 수 있다.Hovenia dulcis extract and tea leaf extract mixture were orally administered 30 minutes before the administration of ethanol and blood was collected at 30 minutes, 1 hour and 2 hours after the administration of ethanol, and the blood alcohol concentration was measured As shown in Fig. 3, the effect of decreasing blood alcohol concentration can be confirmed and compared in 2 hours after administration of ethanol.
구체적으로 에탄올을 투여한 후 2시간 대에서 혈중알코올 농도를 비교한 결과, 헛개나무열매 열수추출물 200mg/kg에 차즈기 잎 열수 추출물을 각각 100, 200mg/kg을 혼합하여 경구 투여한 실험군의 경우, 에탄올만 처리한 대조군(4.1nmol/ul, mM)에 비해 각각 1.0, 0.7nmol/ul(mM) 혈중 알코올 농도가 감소하는 것을 확인 할 수 있었다. 이는 에탄올만 처리한 대조군의 혈중알코올 농도를 100%으로 했을 때, 각각 75.6%, 82.9% 혈중알코올 농도 감소효과를 나타냄을 알 수 있다.As a result of comparing the blood alcohol concentration at 2 hours after ethanol administration, in case of 200 mg / kg of Houttuynia cordata extract and 100 or 200 mg / kg of hot water extract, (MM) blood alcohol concentration was decreased by 1.0 and 0.7 nmol / ul (mM), respectively, compared with the control group treated with ethanol only (4.1 nmol / ul, mM). These results show that 75% and 82.9% of the alcohol concentration in the blood was reduced by 100%, respectively, in the control group treated with ethanol alone.
또한, 헛개나무열매 열수추출물 200, 400mg/kg을 단독 처리한 실험군의 경우, 에탄올만 처리한 대조군(4.1nmol/ul, mM)에 비해 각각 4.0, 2.4nmol/ul(mM) 혈중 알코올 농도가 감소하는 것을 확인 할 수 있었다. 이는 에탄올만 처리한 대조군의 혈중알코올 농도를 100%으로 했을 때, 각각 2.4%, 41.5% 혈중알코올 농도 감소효과를 나타냄을 알 수 있다.In the group treated with 400 mg / kg of hydrolyzate of Hovenia duli fruit juice alone, the blood alcohol concentration was decreased to 4.0 and 2.4 nmol / ul (mM), respectively, compared to the ethanol treated group (4.1 nmol / It is possible to confirm that it is. These results show that the alcohol concentration of ethanol was reduced by 2.4% and 41.5%, respectively, when the alcohol concentration of the control group was 100%.
차즈기 잎 열수추출물 200mg/kg, 400mg/kg을 단독 처리한 실험군의 경우, 에탄올만 처리한 대조군(4.1nmol/ul, mM)에 비해 각각 3.2, 3.1nmol/ul(mM) 혈중 알코올 농도가 감소하는 것을 확인 할 수 있었다. 이는 에탄올만 처리한 대조군의 혈중알코올 농도를 100%으로 했을 때, 각각 22%, 24.4% 혈중알코올 농도 감소효과를 나타냄을 알 수 있다.In the experimental group treated with 200 mg / kg and 400 mg / kg of hot water extract of Chazugi leaves, blood alcohol concentration was decreased to 3.2 and 3.1 nmol / ul (mM), respectively, compared with the ethanol treated group (4.1 nmol / It is possible to confirm that it is. These results show that alcohol concentration was reduced by 22% and 24.4%, respectively, when the ethanol concentration of the control group was 100%.
이러한 결과로부터, 헛개나무열매 열수추출물, 차즈기 잎 열수추출물을 각각 단독으로 처리한 경우보다 헛개나무열매 열수추출물과 차즈기 잎 열수추출물 혼합물 형태로 처리한 경우, 혈중알코올농도 감소효과가 높음을 알 수 있다.
From these results, it was concluded that the effect of reducing the alcohol concentration in the blood was higher when the mixture was treated in the form of a mixture of hot and cold water extracts of Houttuynia fruit and Chazji leaf, .
도4는 헛개나무열매 추출물 및 차즈기 잎 추출물 혼합물의 숙취해소효과 관찰실험에서 혈중알코올 농도를 양성대조군으로 시중에 판매 중인 숙취해소음료(YM)를 기준으로 비교한 그래프를 나타낸 것이다. FIG. 4 is a graph showing a comparison of the blood alcohol concentration with the hangover elimination beverage (YM) being sold on the market as a positive control in the experiment to observe the hangover elimination effect of the mixture of Houttuynia cordata fruit extract and Cha-zhi leaf extract.
구체적으로 양성대조군 시료(YM)을 투여한 후 2시간 대에서 혈중알코올 농도를 비교한 결과, 헛개나무열매 열수추출물 200mg/kg에 차즈기 잎 열수 추출물을 각각 100, 200mg/kg을 혼합하여 경구 투여한 실험군의 경우, 양성대조군 (YM처리군, 400mg/kg)의 혈중알코올 농도를 100%로 했을 때, 각각 24.3%, 16.8% 혈중알코올 농도 함량만을 갖음을 확인하였다. 즉, 양성대조군 (YM처리군, 400mg/kg)의 혈중알코올 농도를 100%로 했을 때, 각각 75.7%, 83.2% 혈중알코올 농도 감소효과를 나타냄을 알 수 있다.As a result of comparing the blood alcohol level at 2 hours after the administration of the positive control sample (YM), 100 mg / kg of the hot water extract of Chamaecyparis obtusa and 200 mg / kg of the hot water extract of Hovenia dulcis In one experimental group, the blood alcohol concentration was 24.3% and 16.8%, respectively, when the blood alcohol concentration of the positive control (YM treated group, 400 mg / kg) was taken as 100%. That is, 75% and 83.2% of the blood alcohol concentration was reduced when the blood alcohol concentration of the positive control group (YM treated group, 400 mg / kg) was taken as 100%, respectively.
또한, 헛개나무열매 열수추출물 200, 400mg/kg을 단독 처리한 실험군의 경우, 양성대조군 (YM처리군, 400mg/kg)의 혈중알코올 농도를 100%로 했을 때, 각각 6.5%, 43.5% 혈중알코올 농도 감소효과를 나타냄을 알 수 있다.In the test group treated with 200 mg of 400 mg / kg of hot-water extract of Hovenia duli fruit, the blood alcohol concentration of 6.5% and 43.5% in the positive control group (YM treated group, 400 mg / kg) The effect of concentration reduction is shown.
차즈기 잎 열수추출물 200mg/kg, 400mg/kg을 단독 처리한 실험군의 경우, 양성대조군 (YM처리군, 400mg/kg)의 혈중알코올 농도를 100%로 했을 때, 각각 25%, 28.3% 혈중알코올 농도 감소효과를 나타냄을 알 수 있다.In the test group treated with 200 mg / kg and 400 mg / kg of hot water extract of Chazugi leaves, the blood alcohol concentration of the positive control group (YM treated group, 400 mg / kg) was 25% and 28.3% The effect of concentration reduction is shown.
이러한 결과로부터, 헛개나무열매 열수추출물과 차조기 잎 열수추출물 혼합물 형태로 처리한 경우, 양성대조군, 헛개나무열매 열수추출물, 차조기 잎 열수추출물을 각각 단독으로 처리한 경우보다 혈중알코올농도 감소효과가 현저하게 높음을 알 수 있다.From these results, it was found that the effect of reducing the concentration of alcohol in blood when treated with the mixture of hot - water extract of Hovenia dulcis and hot - water extract of chinchilla leaf was significantly lower than that of the control group, hot - water extract of Hovenia dulcis High.
이로부터 헛개나무 열매 열수추출물 및 차즈기 잎 열수추출물 혼합물을 실험동물의 체중대비 일정한 비율로 투여함으로서 자연 생산물에 의한 혈중알코올 분해 속도 상승을 포함하여 알코올에 의한 숙취 억제효과를 갖는 것이 확인됨으로서 본 발명에 따른 조성물은 알코올 섭취 의하여 야기되는 숙취의 예방 및 해소에 사용할 수 있다.
From this result, it was confirmed that the mixture of hot water extract of Hovenia duli and hot water extract of Chazji leaf was administered at a certain ratio to the body weight of the experimental animals, and it was confirmed that it has an effect of inhibiting hangover caused by alcohol including an increase in the rate of degradation of blood alcohol by natural products. Can be used for the prevention and resolution of hangover caused by alcohol ingestion.
6. 숙취해소 및 예방용 기능성 식품 제조 6. Manufacture of functional food for hangover and prevention
실시예 1 : 본 발명의 추출물이 포함된 기능성 음료Example 1: Functional beverage containing the extract of the present invention
본 발명의 추출물이 포함된 음료는 본 발명의 방법에 따라 추출된 헛개나무 열매 열수추출물과 차즈기 잎 열수추출물 혼합물을 1:1로 혼합한 10.89중량%와 비타민 B1 0.002중량%를 포함하는 기본조성에 올리고당 0.5~10중량% 및 구연산 0~0.1중량%를 혼합하고, 잔여량의 정제수를 가하여 교반한 후 60~65℃에서 영양 보충용 음료타입의 기능성 식품을 35ml 들이 용기에 충전하고 30분~1시간 동안 살균처리하여 최종 제품으로 제조할 수 있으며, 이때 풍미 부여를 위하여 일반적으로 사용되는 설탕, 당류, 향료등의 첨가제를 소비자의 기호에 맞춰 첨가할 수 있다.The beverage containing the extract of the present invention contains a mixture of 10.89% by weight of a 1: 1 mixture of a mixture of hot and cold water extract of Hovenia duli and tea leaves extracted according to the method of the present invention, and 0.002% by weight of vitamin B1 0.5 to 10% by weight of oligosaccharide and 0 to 0.1% by weight of citric acid were mixed, and the remaining amount of purified water was added to the mixture. The resulting mixture was stirred at 60 to 65 ° C for 30 minutes to 1 hour And sterilized to prepare a final product. At this time, additives such as sugar, saccharides, and fragrance generally used for imparting flavor can be added according to the taste of the consumer.
상기 첨가물은 필요에 따라서 예를 들면 하기의 첨가제의 1종 또는 2종 이상을 첨가 배합할 수 있다. 상기 첨가제에는, 예를 들면 그레이프 프루트, 사과, 오렌지, 레몬, 파인애플, 바나나, 배 등의 각종 과즙(농츱 과즙, 분말 과즙 등이어도 좋다); 비타민류 및 프로비타민류( 팔미트산 레티놀,비스벤티아민(bisbentiamine), 리보플라빈, 염산 피리독신, 시아노코발아민(cyanocobalamine), 아스코르빈산 나트륨, 니코틴산 아미드, 판토텐산 칼슘, 엽산, 비오틴, 콜레칼시페롤 (cholecalciferol), 중주석산콜린, 토코페롤, β-카로틴 등의 수용성 및 지용성 비타민류); 향미료 (레몬플레이버, 오렌지플레이버, 그레이프프루트플레이버, 바닐라 에센스 등); 아미노산, 핵산 및 그들의 염류(글루탐산, 글루탐산 나트륨, 글리신, 알라닌, 아스파라긴산, 아스파라긴산 나트륨, 이노신산 등); 식물섬유 (폴리덱스트로오즈, 펙틴, 크산탄 고무, 아라비아 고무검, 알긴산 등); 미네랄 내지 미량 원소(염화 나트륨, 초산 나트륨, 황산 마그네슘, 염화 칼륨, 염화 마그네슘, 탄산 마그네슘, 염화칼슘, 인산 2칼륨, 인산 1나트륨, 글리세로인산 칼슘, 구연산제1철 나트륨, 구연산철 암모늄, 구연산철, 황산망간, 황산구리, 요오드화나트륨, 솔빈산칼륨, 아연, 망간, 구리, 요오드, 코발트 등)등이 포함된다.
The additives may be added, for example, one or more of the following additives, if necessary. Examples of the additive include various kinds of fruit juice such as grapefruit, apple, orange, lemon, pineapple, banana, and pear (may be farmed fruit juice, powdered fruit juice, etc.); Vitamins and provitamins such as palmitoyl retinol, bisbentiamine, riboflavin, pyridoxine hydrochloride, cyanocobalamine, sodium ascorbate, nicotinamide, calcium pantothenate, folic acid, biotin, Water-soluble and fat-soluble vitamins such as cholecalciferol, choline quartet, tocopherol, beta -carotene and the like); Spices (lemon flavor, orange flavor, grapefruit flavor, vanilla essence, etc.); Amino acids, nucleic acids and salts thereof (glutamic acid, sodium glutamate, glycine, alanine, aspartic acid, sodium aspartate, inosine, etc.); Vegetable fibers (polydextrose, pectin, xanthan gum, gum arabic, alginic acid and the like); Minerals or trace elements such as sodium chloride, sodium acetate, magnesium sulfate, potassium chloride, magnesium chloride, magnesium carbonate, calcium chloride, dipotassium phosphate, disodium phosphate, calcium glycerophosphate, sodium ferrous citrate, , Manganese sulfate, copper sulfate, sodium iodide, potassium sorbate, zinc, manganese, copper, iodine, cobalt, etc.).
실시예 2. 본 발명의 추출물이 포함된 환 및 분말Example 2: A ring and powder containing the extract of the present invention
본 발명의 추출물이 포함된 환은 상기 방법에 따라 추출된 헛개나무 열매 열수추출물과 차즈기 잎 열수추출물 혼합물 70중량%, 알로에 베라 농축액 또는 알로에 알보레센스 분말 5중량%, 산약 20중량%, 찹쌀 전분 5중량%를 반죽한 혼합물을 살균한 후, 밀링기와 환주기를 통해 성형하여 성형된 혼합물을 절환기를 통해 일정량 절단한다. 일정량으로 절단된 혼합물은 정환기(당의기)로 성형한 후 성형된 환을 건조하고 살균한 후 냉각하는 방법으로 얻을 수 있다. 또한 건조살균된 환을 마이크로 단위까지 미세하게 분쇄하여 분말로 제조할 수 있다.
The ring containing the extract of the present invention was prepared by mixing 70% by weight of a mixture of the hot-water extract of Hovenia duli and the hot-water extract of Char-grilled leaf, 5% by weight of aloe vera concentrate or aloe alboresense powder, 20% 5 wt% of the kneaded mixture is sterilized, molded through a milling machine and a ring cycle, and the molded mixture is cut through a switcher to cut a predetermined amount. The mixture cut into a certain amount can be obtained by molding with a circulating machine (sugar group), drying the molded ring, sterilizing and cooling the mixture. In addition, the dry sterilized ring can be finely pulverized into micro-units to produce powder.
숙취해소용 조성물로서 헛개나무 열매 열수추출물과 차즈기 잎 열수추출물 혼합물은 인체에 부작용이 없으면서 숙취해소 작용이 우수하고 간독성 보호효과가 뛰어나기 때문에 이를 유효성분으로 함유하는 건강보조식품은 복용이 용이하고 장기간 보관이 가능하여 음주전·후의 숙취해소 및 간장 보호에 유용하게 사용될 수 있고, 숙취해소 원료를 자연에 서식하는 식물로 대체함으로 제조생산단가 절감과 산업화를 통한 수입대체 및 수출효과를 기대할 수 있을 것이다.As a composition for spoiling hangover, the mixture of hot and cold water extracts of Hovenia duli and Chazji leaves is excellent in the hangover relieving action and has excellent hepatotoxic effect without any adverse effect on the human body. Therefore, the health supplement food containing the effective ingredient is easy to take It can be stored for a long time, so it can be useful for the elimination of hangover before and after drinking, and it can be used for protecting the liver. By replacing the hangover elimination raw material with a plant inhabited by nature, it is possible to expect the effect of import substitution and export by industrial production will be.
Claims (6)
Characterized in that the functional food composition for prevention and elimination of hangover, wherein the weight ratio of Hovenous fruit extract and tea leaf extract is 1: 0.5 to 1, is contained in an amount of 0.01 to 95% by weight of the whole composition Functional food for
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140058133A KR101773232B1 (en) | 2014-05-15 | 2014-05-15 | Composition for preventing and treating hangover comprising extracts of hovenia dulcis thunb and extracts of leaves of perilla frutescens britton var |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140058133A KR101773232B1 (en) | 2014-05-15 | 2014-05-15 | Composition for preventing and treating hangover comprising extracts of hovenia dulcis thunb and extracts of leaves of perilla frutescens britton var |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20150131487A KR20150131487A (en) | 2015-11-25 |
KR101773232B1 true KR101773232B1 (en) | 2017-08-31 |
Family
ID=54845316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140058133A KR101773232B1 (en) | 2014-05-15 | 2014-05-15 | Composition for preventing and treating hangover comprising extracts of hovenia dulcis thunb and extracts of leaves of perilla frutescens britton var |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101773232B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210072320A (en) | 2019-12-09 | 2021-06-17 | 조성덕 | Method for manufacturing hangover-relieving beverages using fruit of barn tree and pueraria lobata |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170015842A (en) * | 2015-07-31 | 2017-02-09 | 재단법인 전남생물산업진흥원 | Composition for treating hangover comprising extracts of fruits of stauntonia hexaphylla |
-
2014
- 2014-05-15 KR KR1020140058133A patent/KR101773232B1/en active IP Right Grant
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210072320A (en) | 2019-12-09 | 2021-06-17 | 조성덕 | Method for manufacturing hangover-relieving beverages using fruit of barn tree and pueraria lobata |
Also Published As
Publication number | Publication date |
---|---|
KR20150131487A (en) | 2015-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101946236B1 (en) | Cosmetical composition with antimicrobial and antioxidant using natural plant extract and cosmetics comprising thereof | |
KR101615199B1 (en) | Functional compositions for relieving hangovers and protecting a liver, healthy food and food additive comprising the same | |
KR102020586B1 (en) | Healthy foods for elderly comprising animal and plant extracts and process for preparation thereof | |
JP2006045212A (en) | Oral composition containing specific quinic acid derivative | |
KR20130121324A (en) | Composition for preventing and treating hangover comprising extracts of leaves of perilla frutescens britton var | |
KR101283775B1 (en) | Pharmaceuticlal composition for anti-tussive activity or discharge of phlegm activity comprising extracts of dendropanax morbifera | |
KR102042798B1 (en) | A method for preparing functional pills comprising extracts of natural materials | |
KR101773232B1 (en) | Composition for preventing and treating hangover comprising extracts of hovenia dulcis thunb and extracts of leaves of perilla frutescens britton var | |
KR101706017B1 (en) | Hepatoprotective composition comprising extracts of fruits of stauntonia hexaphylla for preventing alcoholic liver injury | |
JP2006006318A (en) | Taste-modifying agent | |
WO2007007994A1 (en) | Food composition for improving liver function comprising a lonicera caerulea l. var. edulis extract | |
CN106720801B (en) | Burdock tea rich in inulin | |
KR101768612B1 (en) | Food composition for improving liver function and method of health tea using thereof | |
KR101968891B1 (en) | Composition for treating hangover comprising extracts of fruits of stauntonia hexaphylla | |
JP2005237291A (en) | Health food | |
KR101872937B1 (en) | Manufacturing method of Vitamin Composition | |
KR20150130163A (en) | Hepatoprotective composition comprising extracts of leaves of perilla frutescens britton var for preventing alcoholic liver injury | |
KR101773318B1 (en) | Hepatoprotective composition comprising extracts of fruits of stauntonia hexaphylla for preventing alcoholic liver injury | |
KR101871452B1 (en) | The Opuntia humifusa beverages containing lotus root element method. | |
KR20150120741A (en) | Composition for preventing or improving atopic dermatitis comprising mixture of persimmon peel, persimmon flesh, persimmon leaf and Diospyros lotus leaf as effective component | |
KR20200142768A (en) | Composition for hangover cure conprising oriental herbal extract | |
KR101490030B1 (en) | Cigarette filter FOR ANTI-TUSSIVE ACTIVITY OR DISCHARGE OF PHLEGM ACTIVITY COMPRISING EXTRACTS OF DENDROPANAX MORBIFERA | |
KR102489041B1 (en) | Production method of low salt napa cabbage kimchi using functional spice | |
KR20240105782A (en) | Bamboo salt beverage using Salicornia herbacea and process for preparing the same | |
KR102493688B1 (en) | Manufacturing Method of Strip using Chicken Breast and Strip Composition using Chicken Breast |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
X091 | Application refused [patent] | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20200103 Year of fee payment: 4 |